Skip to content
TrialScanner

NCT05891158

A Study About Fazirsiran in People With and Without Liver Problems

Phase 1CompletedTAKLead

Registry record

Lead sponsor
Takeda
Conditions
Hepatic Impairment
Primary completion
Sep 3, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05891158 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

1 change recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05891158: A Study About Fazirsiran in... | TrialScanner